Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA.
Cell Metab. 2013 Dec 3;18(6):920-33. doi: 10.1016/j.cmet.2013.11.013.
Reversible posttranslational modifications are emerging as critical regulators of mitochondrial proteins and metabolism. Here, we use a label-free quantitative proteomic approach to characterize the lysine succinylome in liver mitochondria and its regulation by the desuccinylase SIRT5. A total of 1,190 unique sites were identified as succinylated, and 386 sites across 140 proteins representing several metabolic pathways including β-oxidation and ketogenesis were significantly hypersuccinylated in Sirt5(-/-) animals. Loss of SIRT5 leads to accumulation of medium- and long-chain acylcarnitines and decreased β-hydroxybutyrate production in vivo. In addition, we demonstrate that SIRT5 regulates succinylation of the rate-limiting ketogenic enzyme 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) both in vivo and in vitro. Finally, mutation of hypersuccinylated residues K83 and K310 on HMGCS2 to glutamic acid strongly inhibits enzymatic activity. Taken together, these findings establish SIRT5 as a global regulator of lysine succinylation in mitochondria and present a mechanism for inhibition of ketogenesis through HMGCS2.
可逆翻译后修饰正在成为线粒体蛋白质和代谢的关键调节因子。在这里,我们使用无标记定量蛋白质组学方法来描述肝线粒体中的赖氨酸琥珀酰化组及其被去琥珀酰酶 SIRT5 的调节。共鉴定出 1190 个独特的琥珀酰化位点,其中 386 个位点分布在 140 种蛋白质中,代表了几种代谢途径,包括β-氧化和酮体生成,在 Sirt5(-/-)动物中显著过琥珀酰化。SIRT5 的缺失导致中链和长链酰基辅酶 A 的积累,并在体内减少β-羟丁酸的产生。此外,我们证明 SIRT5 在线粒体中调节限速酮生成酶 3-羟-3-甲基戊二酰辅酶 A 合酶 2 (HMGCS2) 的琥珀酰化,无论是在体内还是体外。最后,将 HMGCS2 上的过琥珀酰化残基 K83 和 K310 突变为谷氨酸强烈抑制酶活性。总之,这些发现确立了 SIRT5 作为线粒体中赖氨酸琥珀酰化的全局调节剂,并提出了通过 HMGCS2 抑制酮生成的机制。